ORYX TECHNOLOGY CORP
424B1, 1997-04-09
ELECTRICAL INDUSTRIAL APPARATUS
Previous: EXCELSIOR FUNDS, 497, 1997-04-09
Next: CATALYST INTERNATIONAL INC, 4, 1997-04-09




PROSPECTUS

[ORYX LOGO]



3,283,660 Shares of Common Stock



                      40,000 Common Stock Purchase Warrants


                              ORYX TECHNOLOGY CORP.


         This  Prospectus  (the  "Prospectus")  relates to  2,283,660  shares of
Common  Stock,  par value  $.001 per share (the  "Shares")  and 40,000  callable
Common Stock Purchase  Warrants (the  "Warrants"),  of Oryx Technology  Corp., a
Delaware  corporation ("Oryx" or the "Company"),  which may be sold from time to
time by the individuals and entities listed as Selling  Security  Holders herein
(the "Selling Security  Holders").  Each of the Warrants  currently entitles the
holder thereof to purchase 1.9 Shares at an exercise price of $3.50 per Warrant.
The Company will not receive any proceeds from the offering.


- --------------------------------------------------------------------------

         INFORMATION  CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT.  A
REGISTRATION  STATEMENT  RELATING  TO THESE  SECURITIES  HAS BEEN FILED WITH THE
SECURITIES  AND EXCHANGE  COMMISSION.  THESE  SECURITIES MAY NOT BE SOLD NOR MAY
OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION  STATEMENT  BECOMES
EFFECTIVE.  THIS  PROSPECTUS  SHALL  NOT  CONSTITUTE  AN  OFFER  TO  SELL OR THE
SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE  SECURITIES
IN ANY STATE IN WHICH SUCH OFFER,  SOLICITATION  OR SALE WOULD BE UNLAWFUL PRIOR
TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH STATE.

THE SECURITIES  OFFERED  HEREBY INVOLVE A SIGNIFICANT  DEGREE OF RISK. SEE "RISK
FACTORS" AT PAGES 5 TO 12.
                                                ---------------------

         THESE   SECURITIES  HAVE  NOT  BEEN  APPROVED  OR  DISAPPROVED  BY  THE
SECURITIES  AND  EXCHANGE  COMMISSION  NOR HAS THE  COMMISSION  PASSED  UPON THE
ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
- --------------------------------------------------------------------------


                 The date of this Prospectus is March 31, 1997.

<PAGE>
         The Selling Security Holders have advised the Company that they propose
to sell  the  Shares  and the  Warrants,  from  time to time,  publicly  through
broker-dealers  acting as agents for others,  or in private sales.  See "Selling
Security Holders" and "Plan of  Distribution."  The Company will not receive any
of the proceeds  from the sale of the Shares or the Warrants  offered  hereby by
the Selling Security Holders.

         The Company will pay all offering expenses for the offering,  estimated
at $18,071 including (i) the SEC registration fee ($1,571);  (ii) legal fees and
expenses ($7,500); (iii) blue sky fees ($500); (iv) accounting fees and expenses
($7,500);  (v) printing expenses ($500); and (vi) miscellaneous expenses ($500),
but will not pay any discounts or commissions  incurred by the Selling  Security
Holders in connection with the sale of the Shares or Warrants.

                              AVAILABLE INFORMATION

         The  Company  is  subject  to  the  informational  requirements  of the
Securities Exchange Act of 1934, as amended,  and in accordance  therewith files
reports, proxy statements and other information with the Securities and Exchange
Commission  (the  "Commission").   Such  reports,  proxy  statements  and  other
information  filed by the  Company  may be  inspected  and  copied at the public
reference facilities  maintained by the Commission at Judiciary Plaza, 450 Fifth
Street, N.W.,  Washington,  D.C. 20549, and at the Commission's Regional Offices
at Northwestern  Atrium Center,  500 West Madison Street,  Suite 1400,  Chicago,
Illinois  60661-2511 and 7 World Trade Center, New York, New York 10048.  Copies
of such  material  may be  obtained  from the  Public  Reference  Section of the
Commission at Judiciary Plaza, 450 Fifth Street, N.W.,  Washington,  D.C. 20549,
at  prescribed  rates.  The  Commission  also  maintains  an internet  site that
contains  reports,  proxy  and  information  statements  and  other  information
regarding   registrants  that  file   electronically   with  the  Commission  at
http://www.sec.gov.

         This Prospectus,  which  constitutes  part of a Registration  Statement
filed by the Company with the  Commission  under the  Securities Act of 1933, as
amended (the "Act"),  omits certain  information  contained in the  Registration
Statement  in  accordance  with the rules  and  regulations  of the  Commission.
Reference  is hereby  made to the  Registration  Statement  and to the  exhibits
relating  thereto for further  information  with  respect to the Company and the
securities offered hereby.


<PAGE>


                                TABLE OF CONTENTS

                                                                    Page
Available Information........................................          2
Incorporation of Certain Information by Reference............          4
Risk Factors.................................................          5
The Company..................................................         12
Use of Proceeds..............................................         13
Selling Security Holders.....................................         13
Plan of Distribution.........................................         16
Description of Securities....................................         16
Stock Transfer Agent.........................................         20
Legal Matters................................................         20
Experts......................................................         20
Indemnification..............................................         20

         The  Company's  Common  Stock and  Warrants  are quoted on the National
Association  of  Securities  Dealers  Automated  Quotation  System  (Small  Cap)
("NASDAQ")  under the  symbols  "ORYX" and  "ORYXW,"  and on the  Pacific  Stock
Exchange ("PSE") under the symbols "OXT". and "OXTW," respectively. On March 27,
1997,  the closing  price on NASDAQ for the Common Stock was $2.25 per share and
the closing price for the Warrants was $2.00. There have been no recent reported
trades on the PSE.

         The Company will not receive any proceeds from the sale of Common Stock
or Warrants  for the account of the Selling  Security  Holders.  The Company has
informed the Selling Security Holders that the anti-manipulative rules under the
Exchange  Act of 1934,  Rules  10b-6 and 10b-7,  may apply to their sales in the
market and has  furnished  the  Selling  Security  Holders  with a copy of these
rules.  The Company has also informed the Selling  Security  Holders of the need
for  delivery  of  copies  of this  Prospectus  in  connection  with any sale of
securities registered hereunder.


- --------------------------------------------------------------------------

         NO PERSON HAS BEEN  AUTHORIZED TO GIVE ANY  INFORMATION  OR TO MAKE ANY
REPRESENTATION  OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS IN CONNECTION WITH
THE  OFFERING  DESCRIBED  HEREIN  AND,  IF GIVEN OR MADE,  SUCH  INFORMATION  OR
REPRESENTATION MUST NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED BY THE COMPANY.

         THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFERING IN ANY  JURISDICTION TO
ANY PERSON TO WHOM SUCH OFFER WOULD BE UNLAWFUL OR AN OFFERING OF ANY SECURITIES
OTHER THAN THE REGISTERED  SECURITIES TO WHICH IT RELATES.  NEITHER THE DELIVERY
OF THIS  PROSPECTUS NOR ANY OFFER OR SALE MADE HEREUNDER AT ANY TIME SHALL IMPLY
THAT THE INFORMATION PROVIDED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO ITS
DATE. -------------------

<PAGE>

         The  Company  is  subject  to  the  informational  requirements  of the
Securities Exchange Act of 1934 and, in accordance therewith,  files reports and
other information with the Securities and Exchange Commission.

         The Company has previously and intends to furnish its stockholders with
annual  reports  containing  audited  financial  statements  and may  distribute
quarterly reports containing unaudited summary financial information for each of
the first three quarters of each fiscal year.


                INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

         The following  documents  filed by the Company with the  Commission are
incorporated herein by reference:


         1. The  Company's  Annual  Report  on Form  10-KSB as  amended  by Form
10-KSB/A1 for the fiscal year ended February 29, 1996;
 
         2. The Company's  Quarterly Report on Form 10-QSB for the quarter ended
November 30, 1996;

         3. The Company's Current Reports on Forms 8-K filed with the Commission
on January 3, 1997 and February 21, 1997; and

         4. The  description  of the Common  Stock  contained  in the  Company's
Registration Statement on Form 8-A filed with the Commission under Section 12 of
the Exchange Act.


         All  reports and other  documents  filed  pursuant  to Sections  13(a),
13(c), 14 or 15(d) of the Exchange Act subsequent to the date of this Prospectus
and prior to the termination of the offering of the Shares shall be deemed to be
incorporated  by reference in this  Prospectus  and to be a part hereof from the
date of filing of such reports or other documents.  Any statement contained in a
document  incorporated or deemed to be incorporated by reference herein shall be
deemed to be modified or  superseded  for  purposes  of this  Prospectus  to the
extent  that a statement  contained  herein or in any other  subsequently  filed
document  which  also is or is deemed to be  incorporated  by  reference  herein
modifies  or  supersedes  such  statement.  Any such  statement  so  modified or
superseded  shall  not be  deemed,  except  as so  modified  or  superseded,  to
constitute a part of this Prospectus.


         Copies  of any  and  all  documents  that  have  been  incorporated  by
reference  herein,  other than exhibits to such documents,  may be obtained upon
request  without  charge from the Company's  Chief  Financial  Officer,  Mitchel
Underseth,  47341 Bayside Parkway,  Fremont,  California 94538,  (510) 249-1144.
Please specify the information desired when making such request. The information
relating  to the Company  contained  in this  Prospectus  does not purport to be
comprehensive and should be read together with the information  contained in the
documents  or  portions  of  documents  incorporated  by  referenced  into  this
Prospectus.

<PAGE>

                                  RISK FACTORS

         The  securities  offered  hereby  involve a high degree of risk.  It is
impossible  to foresee and  describe  all the risks and  business,  economic and
financial  factors which may affect the Company.  Prospective  investors  should
carefully  consider the risk and speculative  factors,  as well as other matters
set forth  elsewhere in this  Prospectus,  before  making an  investment  in the
Company.

HISTORY OF UNPROFITABILITY; SUBSTANTIAL RECENT OPERATING LOSSES 
AND ACCUMULATED DEFICIT

         Since its initial  public  offering in April 1994,  the Company has not
been  profitable on a quarterly or annual basis except for its most recent three
quarters ended May 31, 1996,  August 31, 1996 and November 30, 1996. At November
30,  1996,  the Company had an  accumulated  deficit of  $7,534,000.  During the
fiscal year ended February 29, 1996, the Company experienced  significant delays
and additional costs in the development of its material analysis,  electrostatic
discharge   testing  and  surge   protection   product  lines  and   experienced
deterioration  of gross margins in the power products  subsidiary,  all of which
have added to the Company's continuing losses. Due to the significant  reduction
in sales to Pitney Bowes,  discussed below, the Company expects that it will not
be profitable  during the fourth  quarter of the fiscal year ended  February 28,
1997 as well as during the first two quarters of the fiscal year ending February
28,  1998.  Therefore,  there  can be no  assurance  that  the  Company  will be
profitable for the fiscal year ended February 28, 1997 or thereafter.

SIGNIFICANT CUSTOMER DEPENDENCE

         For the nine months ended  November 30, 1996 and the fiscal years ended
February 29, 1996 and February 28,  1995,  sales to Pitney Bowes  accounted  for
approximately  50%,  41% and 27% of  consolidated  revenues,  respectively.  The
Company will experience a significant  reduction in sales to Pitney Bowes during
the fourth quarter of 1997 and the 1998 fiscal year. Accordingly,  the Company's
operating  results  will be  materially  and  adversely  affected by the loss of
business from Pitney Bowes.  There can be no assurance that such customer or any
other  customers  will in the future  continue  to  purchase  products  from the
Company at levels that equal or exceed those of prior periods,  if at all. While
the Company actively pursues new customers,  there can be no assurances that the
Company will be  successful  in its efforts,  and any  significant  weakening in
customer demand would have a material adverse effect on the Company.

LIQUIDITY AND CAPITAL RESOURCES

     The Company's working capital was approximately  $5,856,000 at November 30,
1996. On February 28, 1996,  the  Company's  line of credit  terminated  and the
outstanding  balance was repaid.  The  Company's  operating  losses,  increasing
accounts payable, loss of its line of credit and inventory build-up continued or
occurred in the fiscal year ended  February 29, 1996, and together with payments
made to Zenith  Electronics  Corporation  ("Zenith")  and  required  payments on
certain short term  financings,  further  exacerbated  the  Company's  cash flow
needs. During the fourth quarter of the fiscal year ended February 28, 1997, the
Company raised additional capital of

 <PAGE>

$3,510,462  pursuant to  a  private  placement in which it issued  and  sold  an
aggregate  of  2,044,130  shares  of  its  common  stock  to  certain  qualified
institutional  investors  under  Regulation S of the  Securities Act of 1933, as
amended.  The Company is currently pursuing other credit  arrangements and hopes
to establish a line of credit facility by May 31, 1997. Failure to obtain such a
credit  facility  or other  financing,  however,  could have a material  adverse
impact on the Company's growth and liquidity.
NEED FOR ADDITIONAL FINANCING

         The  Company's  current  financial  resources  may not be sufficient to
enable it to satisfy all of its anticipated  financing needs for the fiscal year
ending February 28, 1998. In the event the Company requires additional equity or
debt financing, or attempts to raise capital through an asset sale, there can be
no assurance that such  transactions  can be effected in a timely manner to meet
all the  Company's  needs,  or at all, or that any such  transaction  will be on
terms acceptable to the Company or in the interest of its stockholders.

RISKS OF NEW PHASE OF DEVELOPMENT AND ACQUISITION

         The  Company  has  invested   substantially   in  the   development  of
proprietary  technologies in surface  analysis,  electrostatic  surge testing of
integrated circuits and surge protection,  and has shipped four units of its new
secondary ion mass  spectrometer as well as completed a licensing  agreement for
part of its SurgX technology with an electronic  component  manufacturer.  There
can  be  no  assurance   that  the  Company  will  be   successful   in  further
commercializing   these  technologies  or  any  other  products,  or  developing
financially viable businesses based on these  technologies or products.  Results
of operations in the future will be  influenced by numerous  factors,  including
technological  developments  by the  Company,  its  customers  and  competitors,
increases in expenses  associated  with product  development  and sales  growth,
market  acceptance  of the  Company's  products,  the  ability of the Company to
successfully  control  its costs of  development,  overhead  and other costs and
manage its  operations,  the  capacity  of the Company to develop and manage the
introduction of new products, and by competition. There can be no assurance that
revenue growth will be sustained or profitability on a quarterly or annual basis
will be achieved.  Accordingly,  there can be no assurance that the Company will
be able to implement its business  plan,  expand its  operations and develop and
sustain profitable operations.

         On  December  19,  1996,  Oryx  Power  Products   Corporation   ("Power
Products"), the Company's power products subsidiary, acquired all of the assets,
assumed a portion of the  liabilities,  and hired key personnel of Power Sensors
Corporation,  an Illinois  corporation  ("Power  Sensors")  for 6 percent of the
outstanding  Series  A  Common  Stock of Power  Products  and  cash  payment  of
$120,000.  The Asset Purchase  Agreement for this acquisition  provides that if,
within 3 years of December  19, 1996,  Power  Products is not itself sold in its
entirety to, or  purchased  by, a third party for cash or public  securities  of
such third party or publicly traded as a company whose securities are registered
under the Securities Act of 1933 or is a reporting  company under the Securities
Exchange Act of 1934,  then each of the holders of the Power  Products  Series A
Common  Stock issued in the  acquisition,  shall have the option on that date to
exchange such Common Stock into a non-interest  bearing promissory note of Power
Products  in an amount  equal to $2.50  per  share of  Common  Stock for a total
indebtedness  of $1,500,000.  Power Sensors is a developer and

<PAGE>

manufacturer of DC-to-DC power  conversion  products.  While this acquisition is
intended to provide the Company with entry into the DC to DC power supply market
and to generate sales sufficient to help offset the reduction in sales to Pitney
Bowes as discussed  above,  there can be no  assurance  that the Company will be
able to  successfully  market such  products or that any sales of such  products
will offset any  reductions in the Company's  sales to Pitney Bowes or any other
customer.

RISKS ASSOCIATED WITH MANAGEMENT OF GROWTH; INTERNAL CONTROL DEFICIENCIES

         The Company has recently  experienced  and may  continue to  experience
substantial  growth in the number of employees and the scope of its  operations,
resulting  in  increased  responsibilities  for  management.  To  manage  growth
effectively,  the Company  will need to  continue  to improve  its  operational,
financial and management  information  systems and to develop and maintain sound
internal  controls.  In connection  with the Company's audit for the fiscal year
ended  February 28, 1995,  the Company's  independent  accountants  identified a
reportable  condition in the  Company's  internal  controls  with respect to its
inventory  management  systems as it relates to tracking  the movement of costed
inventory  which  resulted  in  an  adjustment  to  the  fiscal  1995  financial
statements.  Another  reportable  condition was  identified  with respect to the
Company's record keeping for equity  financing and share issuance  transactions.
In connection  with the Company's  audit for the fiscal year ended  February 29,
1996,  the Company's  independent  accountants  identified a further  reportable
condition relating to physical inventory procedures  specifically with regard to
substantial adjustments that resulted from physical inventories taken during the
fiscal year ended February 29, 1996. The resulting adjustments were reflected in
the fiscal 1996 financial  statements.  A reportable  condition indicates that a
material error or irregularity may occur in the Company's quarterly and year-end
financial  statements and may not be detected on a timely basis by the Company's
employees,  thereby  possibly  resulting  in a  misstatement  of  the  Company's
financial  statements.  While the Board of Directors  has  instituted  action to
correct the  preceding  conditions,  there can be no assurance  that the Company
will be able to effectively  achieve or manage any future growth, or develop and
maintain  strong  internal  controls.  Such  failure  could result in a material
adverse  effect on the Company's  financial  condition and results of operations
and could result in a misstatement of operating results.

COST OF POWER CONVERSION PRODUCTS

         In July 1995,  the Company's  contract  with Zenith,  pursuant to which
Zenith manufactured certain power conversion products for the Company at a fixed
price per unit,  expired  in  accordance  with its terms.  Since such time,  the
Company has manufactured  power conversion  products at its facility in Reynosa,
Mexico,  while purchasing  components for such products from various third party
manufacturers  and  distributors.  The Company has purchased many components for
power  conversion  products  from  distributors  at prices which are higher than
those offered directly from manufacturers, and the current market prices of such
components  are  substantially   higher  than  the  prices  of  such  components
anticipated  by the  Company  at the time it entered  into the Zenith  contract.
Accordingly,  the Company  has  incurred  higher  costs in  producing  its power
conversion  products and the  Company's  per unit profit margin on such products
has  decreased.  There  can be no  assurance  that the  Company  will be able to
produce such products at a lower cost or negotiate  more  favorable,  or even as
favorable,  terms for the components thereof, in the future and, therefore,  the
Company's  profit  margin on power  products may be subject to further  erosion,
which would have a material adverse affect on the Company.

RELIANCE ON THIRD PARTY MANUFACTURERS MAY DISRUPT OPERATIONS

         The  Company  relies on  third-party  manufacturers  for the  supply of
substantially all key components for all of its products. The Company's reliance
on outside manufacturers  generally,  and a sole manufacturer or a limited group
of  manufacturers  in  particular,  involves  several risks,  including  without
limitation,  a  potential  inability  to obtain an  adequate  supply of required
components and reduced control over pricing,  quality, cost, and timely delivery
of  components.  Any  inability  to  obtain  adequate  deliveries  or any  other
circumstances  that would  require  the Company to seek  alternative  sources of
supply or to manufacture such components  internally could lead to disruption of
the  operations  of  the  Company,   product  deficiencies,   unanticipated  and
fluctuating   expenses,   unpredictable   revenues,   and  sales  and  marketing
dislocations  that are beyond  the  Company's  control,  and may have a material
adverse effect on the Company's business and operations.

TECHNOLOGICAL CHANGES AFFECTING PRODUCTS AND PRODUCT DEVELOPMENT RISKS

         The design and manufacture of technologically  advanced  components and
equipment  continually undergo rapid and significant  technological  change. The
Company's  success  will  depend  upon its  ability to  maintain  a  competitive
position with respect to its  proprietary  and other enhanced  technology and to
continue  to  attract  and  retain  qualified  personnel  in all  phases  of its
operations.  The  Company's  business  is, to a large  degree,  dependent on the
enhancement  of its  current  products  and  the  development  of new  products.
Critical to the Company's success and future  profitability will be its capacity
to develop new technologies for new product lines and product upgrades.  Product
development  and  enhancement  involve  substantial   research  and  development
expenditures  and a high  degree  of risk,  and there is no  assurance  that the
Company's product  development  efforts will be successful,  will be accepted by
the  market,   or  that  such   development   efforts  can  be  completed  on  a
cost-effective  or  timely  basis.   There  can  be  no  assurance  that  future
technological  developments will not render existing or proposed products of the
Company  uneconomical  or  obsolete or that the  Company  will not be  adversely
affected by competition  or by the future  development  of  commercially  viable
products by others.

QUARTERLY FLUCTUATIONS OF OPERATING RESULTS

         The Company's  quarterly  operating  results have in the past been, and
will in the future be, subject to fluctuation.  The Company's  operating results
are impacted by numerous factors, such as product introductions or modifications
by competitors,  market acceptance of the Company's  products and its customers'
products,  product price changes,  product mix,  purchasing patterns of original
equipment  manufacturers ("OEMs") and other customers,  delays in, or failure to
receive,  orders due to customer  financial  difficulties,  and overall economic
trends.  The Company  plans to introduce  product  upgrades or new product lines
from time-to-time,  which could generate  short-term order fluctuations and have
an adverse impact on sales of certain existing products.  In addition,  customer
orders may involve  competing  capital budget  considerations  for the customer,
thus making the timing of customer orders  difficult to predict and uneven.  Any
delay or failure to receive anticipated orders, or any deferrals or cancellation
of existing orders, would adversely affect the Company's financial  performance.
The Company's  expense levels are based in part on its expectations as to future
revenues and, in particular,  revenue  growth,  and the Company may be unable to
adjust  spending in a timely  manner to  compensate  for any revenue  shortfall.
Accordingly,  operating results in any one quarter could be materially adversely
affected by, among other factors, a failure to receive,  ship or obtain customer
acceptance of sufficient orders in that quarter. Any weakening in demand for the
Company's  products  could  have a  material  adverse  effect  on the  Company's
operating results and the Company's ability to achieve profitability.

BACKLOG AND INVENTORY

         Power  Products,  the Company's  power products  subsidiary,  generally
operates with a substantial backlog due primarily to orders from OEMs for custom
power  supplies,  which generally  comprise  between 30% to 40% of the Company's
total revenues.  However,  Power Products' backlog at the beginning of a quarter
typically  does not include all sales  required to achieve the  Company's  sales
objectives for Power Products for that quarter.  Therefore,  Power Products' net
sales and operating  results for a quarter depend on the Company shipping orders
scheduled to be sold during that  quarter and  obtaining  additional  orders for
products to be sold during that same  quarter.  Moreover,  the terms of customer
purchase orders generally provide that the customer may cancel or reschedule all
or a substantial  portion of the order with limited notice and with little or no
penalty.  The Company has experienced  rescheduling in the past and, to a lesser
extent,  cancellations,  and expects that it will experience such changes in the
future.  If the Company is unable to timely  adjust its parts orders to meet its
actual product demand, the result may be that the Company has a parts or product
inventory which is  substantially  different from the number and mix of products
actually  sold.  Any such inventory  imbalance  could result in inventory  write
downs or other unexpected charges,  contributing to significant  fluctuations in
operating results from quarter to quarter.

         The Company's other  subsidiaries  currently  operate with virtually no
backlog.  Therefore,  because  the Company  ships most of its  current  products
within a short period after  receipt of an order,  the  Company's  net sales and
operating results for a quarter depend on the Company's ability to obtain orders
for and ship  products  within  the same  quarter.  There  can be no  assurance,
however, that the Company will be able to obtain a sufficient level of orders to
obtain annual profitability.

COMPETITION

         The  Company  is  engaged in certain  highly  competitive  and  rapidly
changing  segments  of  the  electronic  components  and  systems  manufacturing
industry in which technological advances,  costs, consistency and reliability of
supply are critical to competitive  position.  In addition,  the competition for
recruitment of personnel in the technologically-advanced  manufacturing industry
is  continuous  and highly  intense.  The Company  competes or may  subsequently
compete,  directly or  indirectly,  with a large number of  companies  which may
provide products or components  comparable to those provided by the Company.  In
addition,   many  present  or  prospective   competitors   are  larger,   better
capitalized,  more established and have greater access to resources necessary to
produce a  competitive  advantage.  In  particular,  there are a large number of
competitors  producing power conversion  products,  many of which are larger and
more established  technology  oriented companies in the United States as well as
low cost  manufacturers  in the Far East who may be expected to  introduce  more
technologically  advanced power conversion products in the future.  There can be
no assurance that the Company will be able to compete effectively in some or all
of its markets.

NO ASSURANCES OF PROTECTION FOR PATENTS AND PROPRIETARY RIGHTS; 
RELIANCE ON TRADE SECRETS

         The Company relies on a combination of patent, copyright, trademark and
trade secret laws,  non-disclosure  agreements and other  intellectual  property
protection  methods  to  protect  its  proprietary  technology.  There can be no
assurance that any existing or  subsequently  obtained  patents will provide the
Company with substantial competitive advantages,  or that challenges will not be
instituted  against the validity or  enforceability  of any patents owned by the
Company,  or if initiated,  that such challenges will not be successful.  To the
extent the Company wishes to assert its patent rights, there can be no assurance
that any claims of the  Company's  patents  will be  sufficient  to protect  the
Company's technology, and the cost of any litigation to uphold the validity of a
patent and prevent infringement can be substantial even if the Company prevails.
In  addition,  there can be no  assurance  that  others  will not  independently
develop   similar   technologies,   duplicate  the  Company's   technology,   or
legitimately  design around the patented  aspects of the  Company's  technology.
Competitors or potential competitors may have filed applications for or received
patents,  and may obtain additional  patents and proprietary  rights relating to
technology  competitive  with that of the Company.  Furthermore,  if  additional
patents do not issue from present or future patent applications, the Company may
be subject to greater competition.

         In certain  cases,  the Company also relies on trade secrets to protect
proprietary  technology  and processes  which it has developed or may develop in
the future.  There can be no assurance that secrecy  obligations will be honored
or that others will not  independently  develop similar or superior  technology.
The protection of proprietary  technology  through claims of trade secret status
has been the subject of increasing  claims and litigation by various  companies,
both in order to protect proprietary rights, and for competitive purposes,  even
where  proprietary  claims are  unsubstantiated.  The prosecution of proprietary
claims or the  defense of such  claims is costly and  uncertain  given the rapid
development of the principles of law pertaining to this area.

NO DIVIDENDS ON COMMON STOCK

         The Company has not paid any cash  dividends  on its Common Stock since
its inception and does not anticipate  paying cash dividends on its Common Stock
in the foreseeable future. Payment of dividends is likely to be restricted under
the terms of any new  credit  facility.  The  future  payment  of  dividends  is
directly   dependent  upon  future  earnings  of  the  Company,   its  financial
requirements  and other  factors  to be  determined  by the  Company's  Board of
Directors,  as well as the possible  consent of any of its prospective  lenders.
For the  foreseeable  future,  it is anticipated  that any earnings which may be
generated  from the Company's  operations  will be used to finance the growth of
the Company and will not be paid to holders of Common Stock.

RISK OF SIGNIFICANT DILUTION


         On December 23, 1996, the Company  issued and sold 1,134,130  shares of
Common  Stock to  various  investors  in a  private  placement  exempt  from the
registration  requirements of the Securities Act under  Regulation S thereunder.
On February 7, 1997, the Company issued and sold an additional 910,000 shares of
Common  Stock in a second  closing  of the same  offering  described  above (the
transactions described in the previous two sentences shall be referred to herein
collectively as the "Regulation S Offering.")

         In  connection  with the  Regulation S Offering,  the Company  retained
Yorkton Securities,  Inc. ("Yorkton") to act as placement agent pursuant to that
certain Agency  Agreement dated as of December 4, 1996 and amended as of January
23, 1997 (the "Agency Agreement").  Under the terms of the Agency Agreement, the
Company issued Yorkton  warrants to purchase  90,730 and 72,800 shares of Common
Stock for a per share  exercise  price of $1.90 (the  "Yorkton  Warrants").  The
Yorkton  Warrants  are  exercisable  for a period of five years from the date of
each closing of the Regulation S Offering.


         As  a  result  of  these  and  various  other  transactions  previously
undertaken  by the  Company  as of  February  7, 1997,  there  were  convertible
securities and warrants and options of the Company currently outstanding for the
conversion and purchase of up to approximately 5,482,000 shares of Common Stock,
which  represent   significant   additional   potential  dilution  for  existing
stockholders  of the Company.  These  underlying  shares of Common Stock are not
included  in  currently  outstanding  shares.  In  addition,  as a result of the
anti-dilution  provisions  included in certain of these  derivative  securities,
there may be further  dilution  based on the price that the Company issues other
securities in the future.

VOLATILITY OF STOCK PRICE

         There can be no  assurance  that the market  price of the Common  Stock
will not decline below the price at which such shares are being offered pursuant
to this Prospectus,  particularly since the market price of the Company's Common
Stock has fluctuated  substantially  since the Company's initial public offering
in April 1994.  The Company  believes  that a variety of factors could cause the
price of the Company's Common Stock to fluctuate  substantially,  including, for
example,  the  Company's  ability to establish a credit  facility to replace its
former  facility with its bank,  announcements  of  developments  related to the
Company's  business,  liquidity and  financial  viability,  fluctuations  in the
Company's  operating  results  and  order  levels,  general  conditions  in  the
Company's industries, the technology industry in general or the United States or
worldwide economy,  announcements of technological innovations,  new products or
product enhancements by the Company or its competitors,  developments in patents
or  other  intellectual  property  rights,  and  developments  in the  Company's
relationships with its customers,  distributors and suppliers.  In addition,  in
recent  years,  the stock  market in general  and the market for shares of small
capitalization  stocks in particular has experienced  extreme price fluctuations
which  have  often been  unrelated  to the  operating  performance  of  affected
companies.  Such  fluctuations  could  adversely  affect the market price of the
Company's  Common  Stock and the  Warrants  and  ability  to  obtain  additional
financing.

AUTHORIZATION OF PREFERRED STOCK

         The Board of Directors is authorized to issue shares of preferred stock
and to fix the dividend,  liquidation,  conversion,  redemption  and the rights,
preferences and limitations of such shares without any further vote or action of
the  stockholders.  Accordingly,  the Board of Directors is  empowered,  without
stockholder  approval,  to issue  preferred  stock with  dividend,  liquidation,
conversion, voting or other rights which could adversely affect the voting power
of other rights of the holders of the Company's  Common  Stock.  In the event of
issuance, the preferred stock could be utilized, under certain circumstances, as
a method of  discouraging  and delaying or preventing a change of control of the
Company.  Although the Company has no present  intention to issue any additional
shares of its preferred  stock,  there can be no assurance that the Company will
not do so in the future.


                                   THE COMPANY

         Oryx Technology Corp.  designs,  manufactures  and markets  specialized
components,  analytical  equipment  and  instrumentation  products  for original
equipment  manufacturers ("OEMs") in the information  technology industry.  This
industry includes office equipment,  computers,  telecommunications and consumer
electronics. The Company markets or has in product development, technologically-
advanced products which perform diagnostic and analytical  functions and address
industry  requirements  for efficient  power  conversion,  surge  protection and
specialized  materials  technology.  The  Company has  concentrated  its product
development  programs in critical areas where the larger manufacturers of office
equipment,   computers,   computer   peripherals   and  other   electronic   and
telecommunications  products  depend upon  complementary  technology and product
support.  The Company  operates in three  distinct  market  segments:  (i) power
conversion  products,  (ii)  electrical  surge  protection  products,  and (iii)
materials analysis and test equipment and specialized materials products.

         In  November  1995,  the Company  made a strategic  decision to improve
business  focus and  execution by  separating  its core  businesses  and placing
assets  for  each  core  business  into  wholly-owned  subsidiaries.  Three  new
subsidiaries were formed:  Oryx Power Products  Corporation  ("Power Products"),
SurgX  Corporation  ("SurgX") and Oryx  Instruments  and  Materials  Corporation
("Instrument  and   Materials").   The  subsidiaries  are  intended  to  provide
additional  management  and  employee  motivation  to increase the value of each
business  through  potential equity ownership tied more closely to each business
unit,  and to position the Company to be better able to seek financing or equity
investment at the subsidiary level in order to develop the Company's businesses.

         On  December  19,  1996,  Power  Products  acquired  all of the assets,
assumed a portion of the  liabilities,  and hired key personnel of Power Sensors
Corporation,  an Illinois  corporation ("Power Sensors") for 6 percent amounting
to 600,000 shares of the outstanding Series A Common Stock of Power Products and
cash payment of $120,000. Power Sensors is a developer and manufacturer of DC to
DC power conversion products.

         Oryx' and its  subsidiaries'  customer base for their  current  product
lines  includes  the  following  OEMs:  Akashic  Memories  Corporation,   Cooper
Industries,  IBM Corporation,  Pitney Bowes,  Seagate Technology,  Inc., Western
Digital Media Corporation,  and Xerox  Corporation.  The Company plans to market
its existing lines,  and, possibly  additional  product lines to these and other
OEMs during fiscal 1998.

         Oryx also derives revenues from sales of products based on its patented
IntrageneTM  ceramic  metallization  and joining  system and from the design and
fabrication of electromagnet systems. IntrageneTM is a proprietary metallurgical
technology  developed  by  Oryx  which  affords  the  Company  the  capacity  to
metallize,   solder  or  braze  a  comprehensive   range  of   difficult-to-join
engineering  ceramics,  graphite and  refractory  metals used in electronic  and
structural applications.

         The Company's  predecessor,  Advanced  Technology,  Inc.  ("ATI"),  was
incorporated  on April 21, 1976 in New Jersey.  On July 25, 1993, ATI formed the
Company as a wholly-owned  Delaware  subsidiary,  and on September 29, 1993, ATI
merged into the Company.  The Company's  principal executive offices are located
at 47341 Bayside Parkway, Fremont, California 94538, and its telephone number is
(510) 249-1144.


                                 USE OF PROCEEDS

         The Company will not receive any proceeds from the sale of Common Stock
for the account of the Selling Security  Holders.  However,  with respect to the
Warrants,  the  Company  will  receive  proceeds  only from the  exercise of the
Warrants,  the  timing  of  which is at the  discretion  of the  holders  of the
Warrants.  In the event all of the Warrants  were to be  exercised,  the Company
would receive net proceeds of approximately $432,476,  after payment of offering
expenses estimated to be approximately  $18,071.  It is anticipated that the net
proceeds,  if any, will be used by the Company for  expansion of operations  and
product  lines and for  working  capital.  The  actual  allocation  of  proceeds
realized  from the  exercise  of the  Warrants  will  depend upon the amount and
timing of such exercises,  the Company's operating revenues and cash position at
such  time and its  working  capital  requirements  during  the  course  of such
exercise  period.  There can be no  assurances  that any of the Warrants will be
exercised.

         While the intended  use of proceeds is  consistent  with the  Company's
current business plan  objectives,  the Company reserves the right to change the
use of proceeds  depending on working  capital  requirements  and  opportunities
afforded to the Company. Pending utilization of the proceeds as described above,
the net proceeds of the offering will be deposited in interest  bearing accounts
or invested in money market instruments, government obligations, certificates of
deposits or similar short-term investment grade interest bearing investments.


                            SELLING SECURITY HOLDERS

         The  following  table  sets  forth  the  name of the  Selling  Security
Holders,  the amount of shares of Common Stock held  directly or  indirectly  or
underlying the Warrants and other derivative  securities of the Company owned by
the Selling Security Holders on the date hereof,  the amount of shares of Common
Stock to be offered by the Selling Security  Holders,  the amount to be owned by
the Selling Security  Holders  following sale of such shares of Common Stock and
the  percentage  of shares of Common  Stock to be owned by the Selling  Security
Holders  following  completion of such offering.  As of November 30, 1996, there
were issued and outstanding  10,918,725 shares of Common Stock of the Company as
to which the percentages referred to below are based.


<PAGE>


SHARES OF COMMON STOCK
<TABLE>

                                                                                     Percentage Owned
Name of Selling                      Number of Shares     Shares to            Before               Shares Owned After
Security Holder                      Owned                be Offered           Offering             Offering
<S>                                        <C>                 <C>                    <C>                   <C>
Saraville Limited (1)                      210,525             210,525                1.9%                  -0-
Value Management & Research (1)
                                            50,000              50,000                  *                   -0-
VMR High Octane Fund Ltd. (1)
                                           842,105             842,105                7.7%                  -0-
Caisse Centrale des Banques
Populaires (1)                              31,500              31,500                  *                   -0-
Govett American Smaller Companies
Trust PLC (1)                              465,000             465,000                4.3%                  -0-
Govett Global Smaller Companies
Investment Trust PLC (1)                    60,000              60,000                  *                   -0-
Chase Manhattan Trustees Ltd. (1)
                                           125,000             125,000                1.1%                  -0-
Royal Bank of Scotland Trust
Company Ltd. (1)                            90,000              90,000                  *                   -0-
VPB Finanz AG (1)                           70,000              70,000                  *                   -0-
Dreadnought Limited (1)                    100,000             100,000                  *                   -0-
Yorkton Securities, Inc. (2)               163,530             163,530                1.5%                  -0-
JW Charles Financial Services,
Inc. (3)                                    76,000              76,000                  *                   -0-

TOTAL                                                        2,283,660
</TABLE>

- -----------------------
*        Represents less than 1%.

(1)      Represents  shares issued in the  Company's  Regulation S offering
         undertaken between December 1996 and February 7, 1997.

(2)      Represents  shares  issuable  upon  exercise of two warrants  issued in
         consideration   for  serving  as  placement  agent  for  the  Company's
         Regulation  S  offering  to  institutional  non-U.S.  investment  firms
         completed on February 7, 1997.  The warrants are  exercisable  at $1.90
         per share for 90,730  shares on or prior to December 24, 2001,  and for
         72,800 shares on or prior to February 7, 2002


(3)      Represents  shares  issuable  upon exercise of 40,000  callable  Common
         Stock  Purchase  Warrants (the  "Warrants")  issued in connection  with
         repurchase by the Company of the Underwriters' Warrant described below.
         Each Warrant entitles the holder to purchase 1.9 shares of Common Stock
         at a price of $3.50 per Warrant.


<PAGE>


WARRANTS

                                     Number of Warrants
Name of Selling                      Owned                Warrants to
Security Holder                                           be Offered

JW Charles Financial Services,             40,000               40,000
Inc. (1)

TOTAL                                                           40,000
- -----------------------
(1)       See Note 3 above.


          Between  December 1996 and February  1997, the Company issued and sold
2,044,130  shares of the Company's  Common Stock to a limited group of qualified
institutional investors which are not "U.S. Persons" (as that term is defined in
Rule 902(o)  under the  Securities  Act of 1933,  as amended (the  "Act")).  The
transaction was intended to be exempt from the registration  requirements of the
Act pursuant to Regulation S thereunder. The Company retained Yorkton Securities
Inc.  ("Yorkton")  to act on a best  efforts  basis  as its  exclusive  agent in
connection with this offering. The Company paid Yorkton commissions and expenses
totaling $388,000 and further issued to Yorkton two warrants to purchase a total
of 163,530 shares of the Company's common stock at a price of $1.90 per share.

          On  December  27,  1996,  the  Company  repurchased  from  JW  Charles
Financial Services, Inc. ("JW Charles"), the Underwriters' Unit Purchase Warrant
(the "Underwriters'  Warrant") issued by the Company to JW Charles in connection
with the Company's  initial public offering of its securities in April 1994. The
Underwriters'  Warrant originally entitled JW Charles to purchase 110,000 Units,
which was  subsequently  increased  to  318,421  Units due to the  anti-dilution
provisions contained therein. In September 1996, however, JW Charles paid to the
Company $371,000 to exercise a portion of the Underwriters'  Warrant and thereby
acquired 100,000 Units. Therefore, on the date of repurchase,  the Underwriters'
Warrant entitled JW Charles to purchase 218,421 Units, with each Unit consisting
of two shares of Common  Stock and one warrant to purchase  1.9 shares of Common
Stock. As consideration  for the repurchase of the  Underwriters'  Warrant,  the
Company  paid to JW Charles  $475,000  and issued to it 40,000  callable  Common
Stock Purchase Warrants (the "Warrants"), with each Warrant entitling the holder
thereof to  purchase  1.9 shares of the  Company's  Common  Stock at an exercise
price of $3.50 until April 6, 1999. This Prospectus also relates to the Warrants
and to the  shares  of Common  Stock  underlying  the  Warrants  as  hereinafter
described.

         The  Company has agreed to pay for all costs and  expenses  incident to
the  issuance,  offer,  sale  and  delivery  of the  Shares  and  the  Warrants,
including,  but not limited to, all expenses and fees of  preparing,  filing and
printing  the  Registration  Statement  and  Prospectus  and  related  exhibits,
amendments and supplements  thereto and mailing of such items.  The Company will
not pay selling  commissions and expenses  associated with any such sales by the
Selling  Security  Holders.  The  Company  has agreed to  indemnify  the Selling
Security  Holders  against civil  liabilities  including  liabilities  under the
Securities  Act of 1933. The Selling  Security  Holders have advised the Company
that sales of the Shares may be made from time to time by or for the  account of
the Selling Security Holders in one or more transactions in the over-the-counter
market,  in  negotiated  transactions  or  otherwise,  at prices  related to the
prevailing market prices or at negotiated prices.

                              PLAN OF DISTRIBUTION

         The  Shares  and  the  Warrants  may be sold  from  time to time by the
Selling Security Holders. Such sales may be made in the over-the-counter  market
or otherwise at prices and at terms then  prevailing or at prices related to the
then current  market price,  or in negotiated  transactions.  The Shares and the
Warrants may be sold by one or more of the following methods:  (i) a block trade
in which the  broker or dealer so  engaged  will  attempt  to sell the Shares as
agent for the Selling Security  Holder;  (ii) ordinary  brokerage  transactions;
(iii)  transactions in which the broker  solicits  purchasers and (iv) privately
negotiated  transactions.  In effecting sales, brokers or dealers engaged by the
Selling   Security   Holders  may  arrange  for  other  brokers  or  dealers  to
participate.  Brokers  or  dealers  may  receive  commissions  from the  Selling
Security Holders in amounts to be negotiated immediately prior to the sale. Such
brokers or dealers and any other participating  brokers or dealers may be deemed
to be "underwriters" within the meaning of the Securities Act in connection with
such sales.

                            DESCRIPTION OF SECURITIES

         The Company is currently authorized to issue up to 25,000,000 shares of
Common  Stock par  value  $.001  per  share,  of which  10,918,725  shares  were
outstanding as of November 30, 1996. The Company is also  authorized to issue up
to 3,000,000  shares of  Preferred  Stock,  par value $.001 per share,  of which
4,500  shares of Series A Preferred  Stock were  outstanding  as of November 30,
1996.

COMMON STOCK

         Each share of Common Stock  entitles  the holders  thereof to one vote.
Holders of Common Stock do not have  cumulative  voting  rights which means that
the holders of more than 50% of the shares  voting for the election of directors
can elect all of the  directors if they choose to do so, and in such event,  the
holders of the  remaining  shares will not be able to elect any  directors.  The
Bylaws of the Company require that only a majority of the issued and outstanding
shares of Common Stock of the Company need be represented to constitute a quorum
and to transact business at a stockholders' meeting.

         Subject to the dividend rights of the holders of any outstanding shares
of Preferred Stock,  holders of shares of Common Stock are entitled to share, on
a ratable basis, such dividends as may be declared by the Board of Directors out
of funds legally available therefor. Upon liquidation, dissolution or winding up
of the Company, after payment to creditors and holders of any outstanding shares
of preferred  stock, the assets of the Company will be divided pro rata on a per
share  basis  among the  holders of the Common  Stock.  The Common  Stock has no
preemptive,  subscription  or  conversion  rights and is not  redeemable  by the
Company.  The Shares of the  Company's  Common  Stock  which may be issued  upon
exercise of the Company's publicly traded warrants (the "Public Warrants"),  and
other warrants and options issued by the Company when issued in accordance  with
the terms  thereof,  will be duly  authorized,  validly  issued,  fully paid and
non-assessable.

COMMON STOCK PURCHASE WARRANTS

         The Public  Warrants  were  issued in  registered  form  pursuant to an
Agreement,  dated April 6, 1994 (the "Warrant  Agreement"),  between the Company
and North  American  Transfer Co., as Warrant Agent (the "Warrant  Agent").  The
following  discussion of certain terms and provisions of the Public  Warrants is
qualified  in its  entirety  by  reference  to the  detailed  provisions  of the
Statement of Rights,  Terms and Conditions for the Public Warrants which forms a
part of the Warrant Agreement.

         Each of the Public Warrants currently entitles the registered holder to
purchase 1.9 shares of Common  Stock.  The Public  Warrants are  exercisable  at
$3.50 per Warrant  which is the  equivalent  of $1.84 per share of Common Stock,
subject to certain further adjustments.  The Public Warrants are entitled to the
benefit of adjustments  in their exercise  prices and in the number of shares of
Common Stock or other  securities  deliverable  upon the exercise thereof in the
event  of a  stock  dividend,  stock  split,  reclassification,  reorganization,
consolidation or merger.

         The Public Warrants may be exercised at any time commencing  October 6,
1994 and  continuing  thereafter  until  April 6, 1999,  unless  such  period is
extended by the Company. After the expiration date, Public Warrant holders shall
have no further rights.  Public  Warrants may be exercised by  surrendering  the
certificate  evidencing  such  Public  Warrant,  with  the form of  election  to
purchase  on the  reverse  side  of  such  certificate  properly  completed  and
executed,  together with payment of the exercise  price and any transfer tax, to
the  Warrant  Agent.  If less than all of the  Public  Warrants  evidenced  by a
warrant  certificate  are exercised,  a new  certificate  will be issued for the
remaining number of Public  Warrants.  Payment of the exercise price may be made
by cash,  bank draft or official  bank or certified  check equal to the exercise
price.

         Public  Warrant  holders do not have any voting or any other  rights as
stockholders  of the  Company.  The Company has the right at any time  beginning
October 6, 1994 to repurchase the Public Warrants, at a price of $.05 per Public
Warrant,  by written notice to the registered  holders  thereof,  mailed 30 days
prior to the  repurchase  date.  The Company may exercise this right only if the
closing  bid  price  for the  Common  Stock  for 20  trading  days  during  a 30
consecutive  trading  day  period  ending no more than 10 days prior to the date
that the notice of repurchase is given,  equals or exceeds $5.10 per share [145%
of the offering price per share,  attributing  no value to the Public  Warrants]
subject to adjustment for stock dividends and stock splits.  Any such repurchase
shall be for all outstanding Public Warrants. If the Company exercises its right
to call  Public  Warrants  for  repurchase,  such Public  Warrants  may still be
exercised until the close of business on the day immediately  preceding the date
fixed for  repurchase.  If any  Public  Warrant  called  for  repurchase  is not
exercised by such time, it will cease to be exercisable,  and the holder thereof
will be entitled only to the  repurchase  price.  Notice of  repurchase  will be
mailed to all holders of Public  Warrants  of record at least  thirty (30) days,
but not more than sixty (60) days,  before the  repurchase  date.  The foregoing
notwithstanding, the Company may not call the Public Warrants at any time that a
current registration statement under the Act is not then in effect.

         The Warrant  Agreement  permits  the  Company  and the  Warrant  Agent,
without  the  consent of Public  Warrant  holders,  to  supplement  or amend the
Warrant  Agreement  in  order  to cure any  ambiguity,  manifest  error or other
mistake,  or to address other matters or questions  arising  thereunder that the
Company  and the  Warrant  Agent deem  necessary  or  desirable  and that do not
adversely affect the interest of any Public Warrant holder.  The Company and the
Warrant Agent may also  supplement  or amend the Warrant  Agreement in any other
respect  with the written  consent of holders of not less than a majority in the
number of the Public Warrants then outstanding;  however,  no such supplement or
amendment  may (i) make any  modification  of the terms  upon  which the  Public
Warrants  are  exercisable  or may be  redeemed;  or (ii) reduce the  percentage
interest  of the  holders of the Public  Warrants  without  the  consent of each
Public Warrant holder affected thereby.

         In order for the holder to exercise a Public Warrant,  there must be an
effective registration  statement,  with a current prospectus,  on file with the
Securities  and  Exchange   Commission  covering  the  shares  of  Common  Stock
underlying  the Public  Warrant,  and the  issuance of such shares to the holder
must be registered, qualified or exempt under the laws of the state in which the
holder resides. If required,  the Company will file a new registration statement
with the  Commission  with  respect  to the  securities  underlying  the  Public
Warrants  prior to the  exercise  of such  Public  Warrants  and will  deliver a
prospectus with respect to such securities to all holders thereof as required by
Section 10(a)(3) of the Securities Act of 1933.

PREFERRED STOCK

         The Company is authorized to issue 3,000,000 shares of Preferred Stock,
par value $.001 per share,  issuable in such  series and  bearing  such  voting,
dividend, conversion,  liquidation and other rights and preferences as the Board
of Directors may determine. Of such shares, 45,000 shares were designated Series
A $25 2%  Convertible  Cumulative  Preferred  Stock  (the  "Series  A  Preferred
Stock"), and 4,500 shares were outstanding as of November 30, 1996.

         Shares of Series A Preferred  Stock accrue  cumulative  preferred  cash
dividends  at the annual  rate of 2% or $0.50 per share,  payable  semi-annually
commencing November 1, 1993. The holders of the Series A Preferred Stock have no
right to have the Company  redeem such shares,  and the Company is not obligated
to redeem such shares under any circumstances. The holders of Series A Preferred
Stock are  entitled to receive,  upon a voluntary  or  involuntary  dissolution,
liquidation or winding up of the Company,  $25.00 per share plus an amount equal
to all accrued and unpaid dividends, if any.

         At the election of the holder thereof, each share of Series A Preferred
Stock is  convertible  into 11.6666  shares of Common Stock,  subject to certain
adjustments.  If all 4,500 shares of outstanding  Series A Preferred  Stock were
converted,  there would be issued approximately 52,650 shares of Common Stock of
the Company.  Holders of Series A Preferred Stock have one vote per share on all
matters  submitted  to  the  stockholders  of  the  Company.  In  addition,  the
affirmative  vote of at least a majority of the  outstanding  Series A Preferred
Stock is required to approve any adverse  change in the  preferences,  rights or
limitations with respect to the Series A Preferred Stock.

INTERIM FINANCING SECURITIES

         In March  1994,  the Company  issued  $150,000  principal  amount of 9%
Promissory  Notes (the "Interim  Notes") and bridge  warrants to purchase 37,500
shares of Common Stock.  The Interim Notes were retired from the proceeds of the
Company's public offering in April 1994.

         Each bridge warrant entitles the holder to purchase one share of Common
Stock at an exercise price of $2.28 per share on or prior to March 31, 1999. The
resale of the  shares of Common  Stock  issuable  upon  exercise  of the  bridge
warrants has been registered in a separate public offering,  and the Company has
agreed to maintain an effective  registration  statement and current  prospectus
concerning  the  issuance  of the shares upon  exercise  of the bridge  warrants
during their term.

         The  Company has also issued  warrants  in the  private  offerings  and
commercial transactions described under "Selling Security Holders."

CAPITALIZATION OF SUBSIDIARIES

         In November 1995, the Company restructured its operations and organized
three initially wholly-owned subsidiaries into which the Company placed its core
businesses and related  assets.  The three  subsidiaries  formed were Oryx Power
Products  Corporation,  SurgX  Corporation  and Oryx  Instruments  and Materials
Corporation  (collectively  the  "Subsidiaries").  Each of the  Subsidiaries was
organized  under  the  laws  of  Delaware  with  authorized   capitalization  of
20,000,000  shares of Class A Common Stock,  5,000,000  shares of Class B Common
Stock and 5,000,000 shares of Preferred Stock for all subsidiaries  except SurgX
Corporation. The Class B Common Stock will be used to fulfill options granted to
members of management and other key employees of the  Subsidiaries.  The Class A
Common  Stock  was  issued  to the  Company  in  exchange  for  all  assets  and
liabilities  including  intellectual  property  associated  with the  respective
businesses.  The Class A Common  Stock and  Class B Common  Stock are  identical
except that the Class A Common Stock possesses a liquidation  preference.  As of
the date hereof,  SurgX and Instruments and Materials each has 10,000,000 shares
of Class A Common Stock issued and  outstanding  and held by the Company.  Power
Products has 10,600,000  shares of Class A Common Stock issued and  outstanding,
with  10,000,000  of such  shares held by the Company and 600,000 of such shares
held by  Power  Sensors  Corporation.  No  shares  of  Class B  Common  Stock or
Preferred Stock have been issued by any of the Subsidiaries.  Power Products has
granted  options  to  purchase  1,177,000  shares of its  Class B Common  Stock,
Instruments  and Materials has granted options to purchase  1,119,000  shares of
its Class B Common  Stock and SurgX has  granted  options  to  purchase  280,000
shares of its Class B Common Stock to management  and key  employees  which will
vest ratably over a period of five years.


                              STOCK TRANSFER AGENT

         The  transfer  agent for the shares of Common  Stock is North  American
Transfer Co., 147 West Merrick Road, Freeport, New York 11520.

                                  LEGAL MATTERS

         Certain legal  matters in  connection  with the Shares and the Warrants
being offered  hereby will be passed upon for the Company by Wise & Shepard LLP,
3030 Hansen Way, Suite 100, Palo Alto, California 94304.

                                     EXPERTS

         The financial  statements  incorporated in this Prospectus by reference
to the Annual  Report on Form  10-KSB/A1  for the year ended  February 29, 1996,
have  been  so  incorporated  in  reliance  on the  report  (which  contains  an
explanatory  paragraph  relating to the Company's ability to continue as a going
concern as described in Note 1 to the financial  statements) of Price Waterhouse
LLP, independent accountants,  given on the authority of said firm as experts in
auditing and accounting.

                                 INDEMNIFICATION

         Section 145 of the General  Corporation  Law of  Delaware,  under which
jurisdiction  the Company is  incorporated,  empowers a corporation to indemnify
any  person  who was or is a party  or is  threatened  to be made a party to any
threatened,  pending or completed  action,  suit or  proceeding,  whether civil,
criminal,  administrative  or investigative by reason of the fact that he or she
is or was a director, officer, employee or agent of the corporation or is or was
serving at the request of the  corporation as a director,  officer,  employee or
agent of another corporation or enterprise.  A corporation may indemnify against
expenses (including  attorneys' fees) and, other than in respect of an action by
or in the right of the corporation, against judgments, fines and amounts paid in
settlement actually and reasonably incurred in connection with such action, suit
or proceeding if the person  indemnified  acted in good faith and in a manner he
or she reasonably  believed to be in or not opposed to the best interests of the
corporation,  and with  respect to any  criminal  action or  proceeding,  had no
reasonable  cause to believe his or her conduct was unlawful.  In the case of an
action by or in the right of the corporation, no indemnification of expenses may
be made in respect to any claim,  issue or matter as to which such person  shall
have been adjudged to be liable to the corporation unless and only to the extent
that the Court of Chancery  or the court in which such action was brought  shall
determine that, despite the adjudication of liability, such person is fairly and
reasonably  entitled to indemnity for such  expenses  which the court shall deem
proper.  Section 145 of the General Corporation Law of Delaware further provides
that to the extent a director, officer, employee or agent of the corporation has
been  successful in the defense of any action,  suit or  proceeding  referred to
above or in the defense of any claim,  issue or matter therein,  he or she shall
be  indemnified  against  expenses  (including  attorneys'  fees)  actually  and
reasonably incurred by him or her in connection therewith.

         The  By-laws  of the  Company  require  the  Company to  indemnify  its
directors  and  officers  to  the  fullest  extent   permitted  by  the  General
Corporation Law of the State of Delaware.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933, as amended, may be permitted to directors, officers and controlling
persons of the Company  pursuant to the foregoing  provisions or otherwise,  the
Company has been  advised  that in the opinion of the  Securities  and  Exchange
Commission,  such  indemnification  is against public policy as expressed in the
Act  and  is,  therefore,   unenforceable.   In  the  event  that  a  claim  for
indemnification  against such liabilities (other than the payment by the Company
of expenses incurred or paid by a director, officer or controlling person of the
Company in the successful defense of any action, suit or proceeding) is asserted
by  such  director,  officer  or  controlling  person  in  connection  with  the
securities  being  registered,  the Company  will,  unless in the opinion of its
counsel the matter has been settled by controlling precedent,  submit to a court
of appropriate  jurisdiction the question whether such  indemnification by it is
against  public policy as expressed in the Act and will be governed by the final
adjudication of such issue.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission